Mayne Pharma is an ASX-listed specialty pharmaceutical Company (ASX: MYX) focused on commercializing novel and generic pharmaceuticals. We offer patients better, safe and more accessible medicines.
Mayne Pharma has a 40-year track record of innovation and success in developing oral drug delivery systems. These technologies have been successfully commercialized in numerous products that continue to be marketed around the world.
Mayne Pharma also has two full service contract development and manufacturing organizations (CDMO) servicing clients worldwide.
Metrics Contract Services – based in Greenville, NC, US
Mayne Contract Services – based in Salisbury, SA, Australia
Here are some key facts about our company:
• 900+ staff
• A$450m market cap
• A$400m in revenue (FY21)
• A$40m invested in R&D and capex (FY21)
• A product portfolio of 90+ marketed products globally
The Company’s corporate values are:
• Empowerment – encouraging everyone to take initiative, enabling growth and achievement.
• Passion – showing pride, enthusiasm and dedication in everything we do.
• Creativity – delivering value and striving to connect new ideas with business realities.
• Agility – operating with timeliness as well as mental, emotional and physical flexibility.
• Integrity – maintaining high ethical standards, demonstrating honesty, and respecting fairness by doing the right thing, even when no one is looking.
• Accountability – accepting our individual and team responsibilities, meeting our commitments, and acknowledging and learning from mistakes.
To learn more, visit us at www.maynepharma.com. Our social media policy: https://bit.ly/3py3L1e
drug delivery technologies, pharmaceutical products, product development services, contract manufacturing